VITT and Second Doses of Covid-19 Vaccine.
作者信息
Lacy Joanne, Pavord Sue, Brown Kevin E
机构信息
UK Health Security Agency, London, United Kingdom.
Oxford University, Oxford, United Kingdom.
出版信息
N Engl J Med. 2022 Jan 6;386(1):95. doi: 10.1056/NEJMc2118507. Epub 2021 Dec 22.
Abstract
摘要
相似文献
1
VITT and Second Doses of Covid-19 Vaccine.
N Engl J Med. 2022 Jan 6;386(1):95. doi: 10.1056/NEJMc2118507. Epub 2021 Dec 22.
2
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
Blood. 2021 Dec 2;138(22):2256-2268. doi: 10.1182/blood.2021013231.
3
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
Blood. 2021 Oct 7;138(14):1269-1277. doi: 10.1182/blood.2021012938.
4
Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2.
Front Immunol. 2022 Jan 12;12:782335. doi: 10.3389/fimmu.2021.782335. eCollection 2021.
5
Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways.
Int J Mol Sci. 2021 Oct 6;22(19):10791. doi: 10.3390/ijms221910791.
6
Validation of the newly proposed Brighton Collaboration case definition for vaccine-induced immune thrombocytopenia and thrombosis.
Vaccine. 2024 Nov 14;42(25):126131. doi: 10.1016/j.vaccine.2024.07.032. Epub 2024 Jul 12.
7
Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
Blood Adv. 2022 Jun 14;6(11):3315-3320. doi: 10.1182/bloodadvances.2021006862.
8
Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
Int J Infect Dis. 2022 Jun;119:130-139. doi: 10.1016/j.ijid.2022.03.034. Epub 2022 Mar 24.
9
No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med. 2021 Sep 30;385(14):1334-1336. doi: 10.1056/NEJMc2111305. Epub 2021 Aug 25.
10
Potential mechanisms of vaccine-induced thrombosis.
Eur J Intern Med. 2022 Nov;105:1-7. doi: 10.1016/j.ejim.2022.08.002. Epub 2022 Aug 8.
引用本文的文献
1
Genetic predisposition to vaccine-induced immune thrombotic thrombocytopenia.
Br J Haematol. 2025 Jan;206(1):387-388. doi: 10.1111/bjh.19885. Epub 2024 Nov 10.
2
Subsequent Vaccination against SARS-CoV-2 after Vaccine-Induced Immune Thrombotic Thrombocytopenia.
J Clin Med. 2024 Sep 14;13(18):5462. doi: 10.3390/jcm13185462.
3
Natural history of anti-PF 4 antibodies in patients with vaccine-induced immune thrombocytopenia and thrombosis.
Blood Transfus. 2024 May;22(3):246-252. doi: 10.2450/BloodTransfus.544. Epub 2024 Jan 29.
4
Reassurance on bleeding and thrombotic events following second dose BNT162b2 and ChAdOx1 COVID-19 vaccines.
Lancet Reg Health Eur. 2023 Jul 31;32:100708. doi: 10.1016/j.lanepe.2023.100708. eCollection 2023 Sep.
5
Vaccine-induced immune thrombotic thrombocytopenia: what do we know hitherto?
Front Med (Lausanne). 2023 May 16;10:1155727. doi: 10.3389/fmed.2023.1155727. eCollection 2023.
6
Platelet-activating functional assay resolution in vaccine-induced immune thrombotic thrombocytopenia: differential alignment to PF4 ELISA platforms.
Res Pract Thromb Haemost. 2023 Mar 25;7(3):100128. doi: 10.1016/j.rpth.2023.100128. eCollection 2023 Mar.
7
Thrombosis with Thrombocytopenia Syndrome (TTS) After ChAdOx1 nCoV-19 Immunization: An Investigative Case Report.
Am J Case Rep. 2023 Mar 18;24:e938878. doi: 10.12659/AJCR.938878.
8
Acute limb ischemia secondary to vaccine-induced thrombotic thrombocytopenia.
Ann Vasc Surg Brief Rep Innov. 2023 Mar;3(1). doi: 10.1016/j.avsurg.2022.100153. Epub 2022 Dec 23.
9
Vaccine-induced immune thrombotic thrombocytopenia.
Blood. 2023 Apr 6;141(14):1659-1665. doi: 10.1182/blood.2022017696.
10
COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes.
Hematol Rep. 2022 Dec 1;14(4):358-372. doi: 10.3390/hematolrep14040050.
本文引用的文献
1
Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine?
Lancet. 2021 Nov 13;398(10313):1801. doi: 10.1016/S0140-6736(21)02285-6.
2
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
N Engl J Med. 2021 Oct 28;385(18):1680-1689. doi: 10.1056/NEJMoa2109908. Epub 2021 Aug 11.
3
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
Blood. 2021 Oct 7;138(14):1269-1277. doi: 10.1182/blood.2021012938.
4
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med. 2021 Jun 10;384(23):2202-2211. doi: 10.1056/NEJMoa2105385. Epub 2021 Apr 16.
5
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
Zotero 插件